Trade Vir Biotechnology, Inc. - VIR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.06 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 10.02 |
| Open | 10.08 |
| 1-Year Change | 0.2% |
| Day's Range | 10.02 - 10.2 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | 10.09 | -0.02 | -0.20% | 10.11 | 10.21 | 9.99 |
| Jan 16, 2025 | 10.02 | -0.46 | -4.39% | 10.48 | 10.48 | 9.90 |
| Jan 15, 2025 | 10.46 | -0.01 | -0.10% | 10.47 | 11.20 | 10.24 |
| Jan 14, 2025 | 10.19 | -0.32 | -3.04% | 10.51 | 10.87 | 9.89 |
| Jan 13, 2025 | 10.48 | -1.27 | -10.81% | 11.75 | 11.92 | 9.99 |
| Jan 10, 2025 | 12.08 | -0.39 | -3.13% | 12.47 | 13.70 | 11.99 |
| Jan 8, 2025 | 12.46 | 0.03 | 0.24% | 12.43 | 14.40 | 11.49 |
| Jan 7, 2025 | 7.86 | -0.02 | -0.25% | 7.88 | 8.15 | 7.80 |
| Jan 6, 2025 | 7.93 | 0.36 | 4.76% | 7.57 | 8.07 | 7.56 |
| Jan 3, 2025 | 7.47 | 0.20 | 2.75% | 7.27 | 7.54 | 7.20 |
| Jan 2, 2025 | 7.24 | -0.02 | -0.28% | 7.26 | 7.56 | 7.21 |
| Dec 31, 2024 | 7.30 | 0.02 | 0.27% | 7.28 | 7.49 | 7.19 |
| Dec 30, 2024 | 7.29 | -0.04 | -0.55% | 7.33 | 7.41 | 7.24 |
| Dec 27, 2024 | 7.44 | 0.16 | 2.20% | 7.28 | 7.59 | 7.25 |
| Dec 26, 2024 | 7.36 | 0.12 | 1.66% | 7.24 | 7.40 | 7.13 |
| Dec 24, 2024 | 7.30 | -0.02 | -0.27% | 7.32 | 7.42 | 7.11 |
| Dec 23, 2024 | 7.31 | -0.01 | -0.14% | 7.32 | 7.46 | 7.23 |
| Dec 20, 2024 | 7.32 | 0.15 | 2.09% | 7.17 | 7.51 | 7.17 |
| Dec 19, 2024 | 7.32 | 0.18 | 2.52% | 7.14 | 7.44 | 7.00 |
| Dec 18, 2024 | 7.12 | -0.22 | -3.00% | 7.34 | 7.58 | 6.99 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Vir Biotechnology Company profile
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus, and VIR-2020 for the prevention of tuberculosis. The company has grant agreement with Bill & Melinda Gates Foundation and National Institutes of Health; option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; collaboration and license agreement Alnylam Pharmaceuticals, Inc.; collaboration, license, and option agreement Visterra, Inc.; license agreement with The Rockefeller University and MedImmune, Inc.; and collaboration with WuXi Biologics and Alnylam Pharmaceuticals, Inc. The company has a research collaboration agreement with the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and Vaccine Research Center to advance characterization and development of human monoclonal antibodies against coronaviruses. It operates in the United States, Oregon, Massachusetts, and Switzerland. The company was founded in 2016 and is headquartered in San Francisco, California.| Industry: | Biotechnology & Medical Research (NEC) |
1800 Owens Street
Suite 900
SAN FRANCISCO
CALIFORNIA 94158
US
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com